Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Short term Debt (2016 - 2022)

Sonoma Pharmaceuticals (SNOA) has 2 years of Short term Debt data on record, last reported at $1.1 million in Q4 2012.

  • For Q4 2012, Short term Debt rose 20.13% year-over-year to $1.1 million; the TTM value through Dec 2012 reached $1.1 million, up 20.13%, while the annual FY2012 figure was $55000.0, 83.68% down from the prior year.
  • Short term Debt reached $1.1 million in Q4 2012 per SNOA's latest filing, down from $1.5 million in the prior quarter.
  • Across five years, Short term Debt topped out at $1.5 million in Q2 2012 and bottomed at $55000.0 in Q1 2012.